Joseph Schinger
Analyst
MeTab
Equibles does not estimate personal net worth.
About Joseph Schinger
Joseph Schinger is recorded as Analyst at MeTab. Joseph Schinger has spoken on 1 earnings call across 1 company, most recently for Vir Biotechnology, Inc. on February 26, 2025. The companies whose calls Joseph Schinger spoke on are classified in the Healthcare sector.
Joseph Schinger on recent calls
“Can you just remind us of the details of the collaboration agreement with El Nilem on the LEB Saran component? I believe it's a cost profit share, but just want to make sure of the details on the cost share.”
Affiliation history
-
MeTab
Analyst
Transcript header (unverified)
Current